The contract manufacturing organization (CMO) and contract development and manufacturing organization (CDMO) market is expected to experience growth, driven by factors such as biologics outsourcing and specialized manufacturing. The market's expansion is linked to the increasing demand for biologics and cell therapy, with some related markets, like b-cell depletion therapy and cell culture media, also projected to grow. The overall pharmaceutical and chemical manufacturing landscape appears to be shifting, with various companies and markets poised for steady growth.